Utilization of inhaled nitric oxide therapy in the newborn – A focus on quality and safety


Thursday, April 22nd, 2021 | 12:00 PM - 1:00 PM CT

Targeted to hospital administrators, quality directors, and other senior-level staff, this webinar helps highlight the need for a shared understanding with healthcare professionals to support the appropriate use of inhaled nitric oxide in newborns. Focused on quality and safety considerations, the presentation highlights the value of teamwork and quality improvement in supporting neonates, staff, and families brought together within the unique environment of the neonatal intensive care unit (NICU).

This webinar will empower you to:
  • Gain a high-level comprehension of the appropriate use of inhaled nitric oxide in neonates, with a specific focus on persistent pulmonary hypertension in the newborn
  • Underscore the importance of and highlight the need for a shared understanding with healthcare professionals of quality and safety considerations for the NICU environment and the vulnerable neonatal population it serves
  • Provide a basis for continued conversation with team members to identify needs and quality improvement approaches to support appropriate utilization of inhaled nitric oxide in neonates


Presenter

Dr.Amir_Ashrafi - Daniel Gest-1

Amir H. Ashrafi, MD

Cardiac Neonatologist, CHOC Children’s Hospital